PTX3 and neoplasm: Preclinical studies have proven that targeting pancreatic stellate cells with ATRA (all-trans-retinoic acid) in combination with specific chemotherapy (gemcitabine-nab-paclitaxel) leads to tumor suppression, possibly by modulating PTX-3 expression [128,129].